Logo
x

Search category

Subscribe Now

EUA

Pfizer-BioNTech’s COVID-19 Vaccine Receive the US FDA’s EUA for COVID-19 in Children Aged 6 Months through 4 Years of Age

Pfizer-BioNTech’s COVID-19 Vaccine Receive the US FDA’s EUA for COVID-19 in Children Aged 6 Months through 4 Years of Age

Pfizer and BioNTech Report EUA Expansion for Booster Dose of COVID-19 Vaccine in Children Aged 5 Through 11 Years

Pfizer and BioNTech Report EUA Expansion for Booster Dose of COVID-19 Vaccine in Children Aged 5 Through 11 Years

Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years

Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose of their COVID-19 Vaccine in Children Aged 5 Through 11 Years

The US FDA Approved First Breathalyzer to Detect COVID-19

The US FDA Approved First Breathalyzer to Detect COVID-19

Novavax and Serum Institute of India’s NVX-CoV2373 Receives the DCGI's EUA for the Treatment of COVID-19 in Adolescents Aged ≥12 to <18 Years in India

Novavax and Serum Institute of India’s NVX-CoV2373 Receives the DCGI's EUA for the Treatment of COVID-19 in Adolescents Aged ≥12 t...

Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose in Older Patients

Pfizer and BioNTech Seek the US FDA’s EUA for Booster Dose in Older Patients

Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2022 PharmaShots - All Rights Reserved.